[123I]Ioflupane SPECT in the assessment of Parkinson's disease in a patient with retinitis pigmentosa

被引：0

作者：

Dondi, Francesco ^{[1
,2
]}

Gregorelli, Michela ^{[1
]}

Albano, Domenico ^{[1
]}

Bertagna, Francesco ^{[1
]}

Giubbini, Raffaele ^{[1
]}

机构：

[1] Univ Brescia, Nucl Med, Spedali Civili Brescia, Brescia, Italy

[2] Spedali Civili Brescia, Nucl Med, Ple Spedali Civili 1, I-25123 Brescia, Italy

来源：

NUCLEAR MEDICINE REVIEW | 2023年 / 26卷

关键词：

retinitis pigmentosa; datscan; I-123]Ioflupane; Parkinson's disease;

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Retinis pigmentosa is a form of retinal dystrophy characterized by pigment deposition resulting in loss of peripheral vision, tunnel vision, night blindness and in some cases full blindness. Parkinson's disease is a progressive extrapyramidal neurological disorder characterized by rigidity, bradykinesia and tremor at rest due to loss of substantia nigra's dopaminergic cell; this loss can be evaluated with [I-123]Ioflupane single-photon emission computed tomography (SPECT). There are growing evidences underlying a possible correlation between these two conditions; in this report we describe a patient affected by retinitis pigmentosa with a positive [I-123]Ioflupane scan underlying a possible connection with Parkinson's disease.

引用

页码：34 / 35

页数：2